You searched for CNS - Labiotech.eu

AI artificial intelligence dementia alzheimer's

News and Trends 13 Jun 2023

How AI can advance research and treatment of CNS disorders

By Xiao Xu, senior research fellow, Cerevance The combination of large-scale biological datasets and developments in artificial intelligence (AI) has revolutionized our understanding and treatment of central nervous system (CNS)…

June 13, 2023 - 3 minutesmins - By External Contributor

More News! 14 Nov 2022

Minoryx and Neuraxpharm form alliance to get rights to new therapy for rare CNS disease

Minoryx Therapeutics and Neuraxpharm Group have announced a strategic alliance for the European rights to a new therapy for rare central nervous system (CNS) disease. The companies have entered into…

November 14, 2022 - 3 minutesmins - By Liza Laws

News and Trends 18 Oct 2022

Empyrean Neuroscience launches with $22M to target CNS disorders

Empyrean Neuroscience, Inc. has launched with $22 million in series A financing and a genetic engineering platform to advance a pipeline of neuroactive compounds targeting disorders of the central nervous…

October 18, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 22 Sep 2022

Research identifies new treatment target for CNS injury and neurological disease

Researchers in Birmingham in the U.K. have identified a potential target for drugs to treat long-term neurological conditions like Alzheimer’s Disease and foster nerve regeneration in central nervous system injuries.…

September 22, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 23 Aug 2022

Gate Neurosciences emerges from stealth to tackle CNS diseases

Gate Neurosciences has officially launched to develop its next-generation therapeutics addressing synaptic dysfunction in patients suffering from central nervous system (CNS) disorders. Gate Neurosciences, a U.S. biotech company, was founded…

August 23, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 5 Jul 2022

EditForce and Mitsubishi Tanabi Pharma to work on gene therapy for CNS

EditForce, Inc. has entered into a license agreement with Mitsubishi Tanabe Pharma Corporation (MTPC) to research, develop and commercialize potential gene therapy products for a specific target disease related to…

July 5, 2022 - 2 minutesmins - By Jim Cornall

Interview 25 Oct 2017

What Could RNA Therapies Do for the Treatment of CNS Disorders?

Evelyn chatted with Thomas de Vlaam to find out what his company, Amylon, is working on and how it hopes to change the field fighting CNS disorders. De Vlaam came…

October 25, 2017 - 3 minutesmins - By Alex Dale

Startup Scout 13 Oct 2017

This French Biotech is Taking On CNS Diseases of the Young and the Elderly

This week we're in Castres in the South of France to visit Neurolixis. This biotech is taking on diseases of the CNS, such as Parkinson's, depression and schizophrenia. Mission: Neurolixis…

October 13, 2017 - 2 minutesmins - By Alex Dale

Weekly Roundup 24 Nov 2023

Viva’s $210 million round; Merck grabs Caraway for $610 million; Genentech signs a deal with NVIDIA

Here is Labiotech’s weekly roundup of the latest biotech news. Whether it is partnerships, clinical trials, or fundraising, we have got you covered. Stay in the loop by subscribing to…

November 24, 2023 - 14 minutesmins - By Roohi Mariam Peter

Opinion 25 Oct 2023

Microbiome: are we ready for third generation live biotherapeutics?

The microbiome sector has come a long way. From liquidizing fecal matter in a kitchen appliance for direct insertion into the intestine to the encapsulation of dried matter for oral…

October 25, 2023 - 11 minutesmins - By External Contributor

Best in Biotech 3 Oct 2023

Five impactful biotech companies to know in New York

New York - the place where people of all backgrounds come with hopes and dreams of making a better life for themselves - is just recently becoming a life sciences…

October 3, 2023 - 8 minutesmins - By Willow Shah-Neville

In Depth 2 Oct 2023

PIPEs in biotech fundraising: is this growing trend fueled by economic uncertainty here to stay?

This past year has not been very sympathetic to fundraisers in the biotech industry. As the economic downturn grinds on, many companies are in need of funds to stay afloat.…

October 2, 2023 - 7 minutesmins - By Roohi Mariam Peter

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Power your event with partnering to deliver attendee ROI. Learn more!

Download Inpart’s latest report

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inpart, the leading platform for biopharma partnering